Actively Recruiting
Best Assessment of Sore Throat and Antibiotic Prescribing
Led by Vastra Gotaland Region · Updated on 2026-03-16
450
Participants Needed
4
Research Sites
N/A
Total Duration
On this page
Sponsors
V
Vastra Gotaland Region
Lead Sponsor
G
Göteborg University
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are evaluating how changing the way patients with a sore throat are assessed might reduce unnecessary antibiotic use. This study compares whether medical practitioners, nurses, or pharmacists are the best initial assessors for patients with sore throat symptoms. It also investigates the presence of the SARS-CoV-2 virus in these patients, reflecting changes in COVID-19's impact over time and its transition from pandemic to endemic. The study involves three groups where patients with acute sore throat are first assessed either by a physician, a nurse, or a pharmacist. Each assessor follows the current Swedish guideline, which recommends no antibiotics or testing for patients with fewer Centor criteria and testing plus antibiotics consideration only if Group A Streptococcus (GAS) is present for those with more Centor criteria. The pharmacist assessment is not standard practice in Sweden but is included as an experimental approach. Participants will be evaluated immediately after their consultation for guideline adherence, illness severity, patient type, and presence of SARS-CoV-2. The study monitors these outcomes to understand the best patient flow for sore throat management and the role of COVID-19 in these cases. The total participation duration aligns with the consultation and immediate post-consultation assessment, with no extended long-term follow-up mentioned.
CONDITIONS
Brief Title
Best Assessment of Sore Throat and Antibiotic Prescribing
Who Can Participate
Eligibility Criteria
You may qualify if you...
- The patient is attending a primary health care centre or pharmacy with a sore throat as the main complaint
- Male or female, aged 6 years or older
- Fluent in Swedish for reading, writing, and conversation (applicable to caregivers/parents/guardians for children)
- Mentally able to understand and give informed consent by signing the consent form
- Signed and dated informed consent form provided
You will not qualify if you...
- Illness episode classified as potentially complicated or potentially critically ill
- Presence of SARS-CoV-2 virus in patients initially assessed by pharmacists in their cluster
- Patient requests to be withdrawn from the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Immediately after the consultation
Participants with acute sore throat are assessed by a physician, nurse, or pharmacist following the current Swedish guideline to manage their condition.
1 visit (in-person)
Trial Site Locations
Total: 4 locations
1
Apoteket
Stenungsund, Sweden, 4430
Actively Recruiting
2
Närhälsan Stenungsund Vårdcentral
Stenungsund, Sweden, 44430
Actively Recruiting
3
Praktikertjänst Hälsobrunnen Vårdcentral
Ulricehamn, Sweden, 52337
Actively Recruiting
4
Apoteksgruppen
Ulricehamn, Sweden
Actively Recruiting
Research Team
C
Carl Wikberg, PhD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here